These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 8898373

  • 1. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.
    Samad F, Loskutoff DJ.
    Mol Med; 1996 Sep; 2(5):568-82. PubMed ID: 8898373
    [Abstract] [Full Text] [Related]

  • 2. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
    Samad F, Yamamoto K, Pandey M, Loskutoff DJ.
    Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
    [Abstract] [Full Text] [Related]

  • 3. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.
    Samad F, Yamamoto K, Loskutoff DJ.
    J Clin Invest; 1996 Jan 01; 97(1):37-46. PubMed ID: 8550848
    [Abstract] [Full Text] [Related]

  • 4. Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes.
    Samad F, Pandey M, Bell PA, Loskutoff DJ.
    Mol Med; 2000 Aug 01; 6(8):680-92. PubMed ID: 11055587
    [Abstract] [Full Text] [Related]

  • 5. Obesity enhances the induction of plasminogen activator inhibitor-1 by restraint stress: a possible mechanism of stress-induced renal fibrin deposition in obese mice.
    Yamamoto K, Kojima T, Adachi T, Hayashi M, Matsushita T, Takamatsu J, Loskutoff DJ, Saito H.
    J Thromb Haemost; 2005 Jul 01; 3(7):1495-502. PubMed ID: 15978107
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB, Ma LJ.
    Am J Physiol Endocrinol Metab; 2006 Jan 01; 290(1):E103-E113. PubMed ID: 16144810
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes.
    Seki T, Miyasu T, Noguchi T, Hamasaki A, Sasaki R, Ozawa Y, Okukita K, Declerck PJ, Ariga T.
    J Cell Physiol; 2001 Oct 01; 189(1):72-8. PubMed ID: 11573206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes.
    Harte AL, McTernan PG, McTernan CL, Smith SA, Barnett AH, Kumar S.
    Diabetes Obes Metab; 2003 Sep 01; 5(5):302-10. PubMed ID: 12940867
    [Abstract] [Full Text] [Related]

  • 12. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Sentocnik JT, Stegnar M, Juhan-Vague I.
    Diabetologia; 2001 Nov 01; 44(11):2025-31. PubMed ID: 11719834
    [Abstract] [Full Text] [Related]

  • 13. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
    Oishi K, Ohkura N, Matsuda J, Ishida N.
    Thromb Haemost; 2007 Oct 01; 98(4):864-70. PubMed ID: 17938813
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes.
    Pandey M, Loskutoff DJ, Samad F.
    FASEB J; 2005 Aug 01; 19(10):1317-9. PubMed ID: 15928193
    [Abstract] [Full Text] [Related]

  • 15. Tissue factor gene expression in the adipose tissues of obese mice.
    Samad F, Pandey M, Loskutoff DJ.
    Proc Natl Acad Sci U S A; 1998 Jun 23; 95(13):7591-6. PubMed ID: 9636194
    [Abstract] [Full Text] [Related]

  • 16. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
    Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I.
    Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1262-8. PubMed ID: 12750120
    [Abstract] [Full Text] [Related]

  • 17. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
    Sato Y, Dong J, Imagawa S, Ishimori N, Furumoto T, Tsutsui H, Sobel BE, Fujii S.
    Coron Artery Dis; 2008 Aug 01; 19(5):355-61. PubMed ID: 18607173
    [Abstract] [Full Text] [Related]

  • 18. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines.
    Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM.
    J Clin Endocrinol Metab; 1999 Nov 01; 84(11):4097-105. PubMed ID: 10566656
    [Abstract] [Full Text] [Related]

  • 19. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.
    Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, Juhan-Vague I.
    Arterioscler Thromb Vasc Biol; 2000 Apr 01; 20(4):1150-4. PubMed ID: 10764686
    [Abstract] [Full Text] [Related]

  • 20. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease.
    Lundgren CH, Brown SL, Nordt TK, Sobel BE, Fujii S.
    Circulation; 1996 Jan 01; 93(1):106-10. PubMed ID: 8616916
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.